|
US3622663A
(en)
|
1968-06-13 |
1971-11-23 |
American Home Prod |
Purification of viruses on treated calcium dihydrogen orthophosphate monohydrate adsorbent
|
|
US3919044A
(en)
|
1973-03-28 |
1975-11-11 |
Armour Pharma |
Processes for concentrating and purifying viruses and viral antigens
|
|
SU579309A1
(ru)
|
1973-11-16 |
1977-11-05 |
Ленинградский Политехнический Институт Им.М.И.Калинина |
Способ получени вакцины
|
|
FR2475572A1
(fr)
|
1980-02-11 |
1981-08-14 |
Pasteur Institut |
Procede pour l'obtention de fragments de virus a enveloppe lipidique, en particulier d'antigenes utilisables comme vaccins, produits obtenus et applications
|
|
JPS6147186A
(ja)
|
1984-08-09 |
1986-03-07 |
Chemo Sero Therapeut Res Inst |
インフルエンザウイルスの精製方法
|
|
JPS6147185A
(ja)
|
1984-08-09 |
1986-03-07 |
Chemo Sero Therapeut Res Inst |
日本脳炎ウイルスの精製方法
|
|
JPS6147187A
(ja)
|
1984-08-10 |
1986-03-07 |
Chemo Sero Therapeut Res Inst |
狂犬病ウイルスの精製方法
|
|
US6265149B1
(en)
|
1986-01-22 |
2001-07-24 |
Institut Pasteur |
In vitro diagnostic methods and kits for the detection of HIV-2-specific antibodies
|
|
US5824482A
(en)
|
1986-06-23 |
1998-10-20 |
Institut Pasteur |
Purification, cloning, and characterization of a novel human immunodeficiency virus LAVMAL
|
|
US4814268A
(en)
|
1986-10-06 |
1989-03-21 |
Kreider John W |
Methods for propagating fastidious human viruses and for producing purified suspensions thereof
|
|
US4859597A
(en)
*
|
1987-07-27 |
1989-08-22 |
Igene Biotechnology, Inc. |
Production of phage and phage-associated lysin
|
|
NZ225583A
(en)
|
1987-08-06 |
1991-07-26 |
Merck & Co Inc |
Process for purifying hepatitis a virions (hav)
|
|
US5268292A
(en)
|
1988-06-27 |
1993-12-07 |
Robertson Betty H |
Reproducible generation of high yields of hepatitis A virus by cell culture
|
|
GB8914968D0
(en)
|
1989-06-29 |
1989-08-23 |
Connaught Lab |
Production of virus and purification of viral envelope proteins for vaccine use
|
|
US5719051A
(en)
|
1989-12-22 |
1998-02-17 |
Immuno Aktiengesellschaft |
Perfusion system and a method for the large scale production of virus or virus antigen
|
|
DE4003543A1
(de)
|
1990-02-06 |
1991-08-08 |
Orpegen Med Molekularbioforsch |
Verfahren zur abreicherung von viren in loesungen und zur bestimmung der abreicherungsrate von viren
|
|
US6709811B1
(en)
|
1990-05-24 |
2004-03-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Versatile reagent for detecting murine leukemia viruses
|
|
DE69009066T3
(de)
|
1990-06-15 |
2001-07-19 |
Innogenetics N.V., Gent |
SIV cpz-ant Retrovirus und seine Anwendungen.
|
|
IT1248075B
(it)
|
1991-06-18 |
1995-01-05 |
Sclavo Spa |
Processo per la purificazione del virus dell'epatite a (hav), virus cosi` purificato e composizioni vaccinali che lo contengono.
|
|
FR2686097B1
(fr)
|
1992-01-14 |
1994-12-30 |
Rhone Merieux |
Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie.
|
|
US5658779A
(en)
|
1992-03-20 |
1997-08-19 |
Ligochem, Inc. |
Method of adsorbing viruses from fluid compositions
|
|
US5602023A
(en)
|
1992-03-24 |
1997-02-11 |
Csatary; Laszlo K. |
Pharmaceutical product containing live, stabilized virus for the therapy of viral and malignant diseases and process for preparing the same
|
|
ATE174382T1
(de)
|
1992-10-06 |
1998-12-15 |
Dade Behring Marburg Gmbh |
Retrovirus aus der hiv-gruppe und dessen verwendung
|
|
PT751988E
(pt)
|
1994-03-22 |
2000-05-31 |
Immune Response Corp Inc |
Producao e isolamento altamente eficientes de particulas virais
|
|
FR2723740B1
(fr)
|
1994-08-16 |
1996-11-08 |
Pasteur Merieux Serums Vacc |
Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
|
|
AU704391B2
(en)
|
1994-10-28 |
1999-04-22 |
Trustees Of The University Of Pennsylvania, The |
Improved adenovirus and methods of use thereof
|
|
US5756341A
(en)
|
1994-11-10 |
1998-05-26 |
Immuno Ag |
Method for controlling the infectivity of viruses
|
|
US5837520A
(en)
|
1995-03-07 |
1998-11-17 |
Canji, Inc. |
Method of purification of viral vectors
|
|
US6281010B1
(en)
|
1995-06-05 |
2001-08-28 |
The Trustees Of The University Of Pennsylvania |
Adenovirus gene therapy vehicle and cell line
|
|
FR2737730B1
(fr)
|
1995-08-10 |
1997-09-05 |
Pasteur Merieux Serums Vacc |
Procede de purification de virus par chromatographie
|
|
US5840565A
(en)
|
1995-08-22 |
1998-11-24 |
The Regents Of The University Of California |
Methods for enhancing the production of viral vaccines in PKR-deficient cell culture
|
|
WO1997008298A1
(en)
|
1995-08-30 |
1997-03-06 |
Genzyme Corporation |
Chromatographic purification of adenovirus and aav
|
|
US6194192B1
(en)
|
1996-02-29 |
2001-02-27 |
Takara Shuzo Co., Ltd. |
Method of purifying and removing viruses
|
|
EP0904393A4
(en)
|
1996-03-29 |
1999-09-08 |
Univ Otago |
PARAPOXVIRUS VECTORS
|
|
CZ438398A3
(cs)
|
1996-07-01 |
1999-03-17 |
Rhone-Poulenc Rorer S. A. |
Způsob přípravy rekombinantních adenovirů
|
|
US7732129B1
(en)
|
1998-12-01 |
2010-06-08 |
Crucell Holland B.V. |
Method for the production and purification of adenoviral vectors
|
|
DE69737107T2
(de)
|
1996-11-20 |
2007-07-12 |
Introgen Therapeutics Inc., Austin |
Ein verbessertes verfahren zur produktion und reinigung von adenoviralen vektoren
|
|
FR2756297B1
(fr)
|
1996-11-22 |
1999-01-08 |
Centre Nat Rech Scient |
Procede de production de virus recombinants
|
|
US6261823B1
(en)
|
1996-12-13 |
2001-07-17 |
Schering Corporation |
Methods for purifying viruses
|
|
US6544769B1
(en)
|
1996-12-13 |
2003-04-08 |
Schering Corporation |
Compostions comprising viruses and methods for concentrating virus preparations
|
|
ZA982950B
(en)
|
1997-04-08 |
1998-10-19 |
Merck & Co Inc |
Stabilized human papillomavirus formulations
|
|
US6995006B2
(en)
|
1997-09-05 |
2006-02-07 |
Targeted Genetics Corporation |
Methods for generating high titer helper-free preparations of released recombinant AAV vectors
|
|
US6410300B1
(en)
|
1998-01-12 |
2002-06-25 |
The University Of North Carolina At Chapel Hill |
Methods and formulations for mediating adeno-associated virus (AAV) attachment and infection and methods for purifying AAV
|
|
US6037456A
(en)
|
1998-03-10 |
2000-03-14 |
Biosource Technologies, Inc. |
Process for isolating and purifying viruses, soluble proteins and peptides from plant sources
|
|
US5994134A
(en)
|
1998-05-04 |
1999-11-30 |
Canji, Inc. |
Viral production process
|
|
EP1080218A1
(en)
|
1998-05-27 |
2001-03-07 |
University of Florida |
Method of preparing recombinant adeno-associated virus compositions by using an iodixanol gradient
|
|
PT1105466E
(pt)
|
1998-08-14 |
2006-07-31 |
Merck & Co Inc |
Processo para a purificacao de particulas tipo virus do papilomavirus humano
|
|
US6383794B1
(en)
|
1998-08-24 |
2002-05-07 |
Uab Research Foundation |
Methods of producing high titer recombinant adeno-associated virus
|
|
WO2000028004A1
(en)
|
1998-11-10 |
2000-05-18 |
The University Of North Carolina At Chapel Hill |
Virus vectors and methods of making and administering the same
|
|
CN1087032C
(zh)
*
|
1998-12-14 |
2002-07-03 |
彭朝晖 |
一种生产重组腺病毒的方法
|
|
FR2787465A1
(fr)
|
1998-12-21 |
2000-06-23 |
Transgene Sa |
Procede d'inactivation des virus enveloppes dans une preparation virale de virus non enveloppes
|
|
CA2356373A1
(fr)
*
|
1998-12-31 |
2000-07-13 |
Aventis Pharma S.A. |
Methode de separation de particules virales
|
|
US6387368B1
(en)
|
1999-02-08 |
2002-05-14 |
The Trustees Of The University Of Pennsylvania |
Hybrid adenovirus-AAV virus and methods of use thereof
|
|
US6793926B1
(en)
|
1999-05-27 |
2004-09-21 |
Genovo, Inc. |
Methods for production of a recombinant adeno-associated virus
|
|
US6316185B1
(en)
|
1999-09-29 |
2001-11-13 |
Mountain View Pharmaceuticals, Inc. |
Quantitation of viruses by light scattering
|
|
US6861001B2
(en)
|
1999-12-02 |
2005-03-01 |
The General Hospital Corporation |
Methods for removal, purification, and concentration of viruses, and methods of therapy based thereupon
|
|
CA2395820A1
(en)
|
1999-12-29 |
2001-07-05 |
Genzyme Corporation |
Method using filtration aids for the separation of virus vectors from nucleic acids and other cellular contaminants
|
|
TWI289158B
(en)
|
2000-08-10 |
2007-11-01 |
Oncolytics Biotech Inc |
Method of producing infectious reovirus
|
|
WO2002018550A1
(en)
|
2000-08-25 |
2002-03-07 |
The General Hospital Corporation |
Selective precipitation of viruses
|
|
DE10144903A1
(de)
|
2001-09-12 |
2003-03-27 |
Chiron Behring Gmbh & Co |
Vermehrung von Viren in Zellkultur
|
|
US7195905B2
(en)
|
2001-12-10 |
2007-03-27 |
Baxter Healthcare S.A. |
Enveloped virus vaccine and method for production
|
|
US6825027B2
(en)
|
2001-12-10 |
2004-11-30 |
Baxter Healthcare S.A. |
Method of production of purified hepatitis a virus particles and vaccine preparation
|
|
US6951752B2
(en)
|
2001-12-10 |
2005-10-04 |
Bexter Healthcare S.A. |
Method for large scale production of virus antigen
|
|
WO2003049763A1
(en)
|
2001-12-12 |
2003-06-19 |
Fh Faulding & Co Limited |
Composition for the preservation of viruses
|
|
WO2003084479A2
(en)
|
2002-03-29 |
2003-10-16 |
Merck & Co., Inc. |
Large scale methods of producing adenovirus and adenovirus seed stocks
|
|
DE60319210T2
(de)
|
2002-03-29 |
2009-02-12 |
Merck & Co., Inc. |
Verfahren zur virusproduktion
|
|
ES2323454T5
(es)
|
2002-04-30 |
2012-11-14 |
Oncolytics Biotech Inc. |
Procedimiento mejorado de purificación de virus
|
|
ATE360683T1
(de)
|
2002-05-14 |
2007-05-15 |
Merck & Co Inc |
Verfahren zur reinigung von adenovirus
|
|
US7419817B2
(en)
|
2002-05-17 |
2008-09-02 |
The United States Of America As Represented By The Secretary Department Of Health And Human Services, Nih. |
Scalable purification of AAV2, AAV4 or AAV5 using ion-exchange chromatography
|
|
WO2003103605A2
(en)
|
2002-06-07 |
2003-12-18 |
Large Scale Biology Corporation |
Flexible vaccine assembly and vaccine delivery platform
|
|
AU2003279240A1
(en)
|
2002-06-21 |
2004-01-06 |
Genetix Pharmaceuticals, Inc. |
Methods for purifying viral particles for gene therapy
|
|
US20060228334A1
(en)
*
|
2002-07-10 |
2006-10-12 |
Manuel Rosa-Calatrava |
Modified adenoviral fiber with ablated to cellular receptors
|
|
PL215169B1
(pl)
|
2002-09-05 |
2013-10-31 |
Bavarian Nordic As |
Sposób amplifikacji wirusów, kompozycja zawierajaca pokswirusa uzyskanego tym sposobem oraz jego zastosowanie do otrzymywania szczepionki
|
|
US20050009168A1
(en)
|
2003-05-12 |
2005-01-13 |
Robbins Joan Marie |
Methods and apparatus for Adeno associated virus purification
|
|
AU2004249199B2
(en)
|
2003-06-18 |
2008-07-24 |
Onyx Pharmaceuticals, Inc. |
Method for purifying virus
|
|
US20070275449A1
(en)
|
2003-10-15 |
2007-11-29 |
Vector Gene Technology Company Ltd. |
Method for Large-Scale Production, Isolation, Purification and the Uses of Multi-Type Recombinant Adeno-Associated Virus Vectors
|
|
JP2007515172A
(ja)
*
|
2003-12-23 |
2007-06-14 |
シェーリング コーポレイション |
無血清培地懸濁培養において安定なａ５４９細胞株を生成するための方法
|
|
WO2005080556A2
(en)
|
2004-02-23 |
2005-09-01 |
Crucell Holland B.V. |
Virus purification methods
|
|
US20080254067A1
(en)
|
2004-05-20 |
2008-10-16 |
Id Biomedical Corporation |
Process for the Production of an Influenza Vaccine
|
|
ES2647477T3
(es)
|
2004-06-01 |
2017-12-21 |
Genzyme Corporation |
Composiciones y métodos para prevenir la agregación del vector AAV
|
|
DE102004049290A1
(de)
|
2004-10-09 |
2006-04-20 |
Bayer Healthcare Ag |
Verfahren zur Herstellung von Virusmaterial
|
|
US7901921B2
(en)
|
2004-10-22 |
2011-03-08 |
Oncolytics Biotech Inc. |
Viral purification methods
|
|
WO2006052302A2
(en)
|
2004-11-03 |
2006-05-18 |
Introgen Therapeutics Inc. |
Method of producing and purifying adenoviral vectors
|
|
US20060281075A1
(en)
|
2004-12-22 |
2006-12-14 |
Large Scale Biology Corporation |
Purification of viruses, proteins and nucleic acids
|
|
US7344839B2
(en)
|
2004-12-23 |
2008-03-18 |
Aurx, Inc. |
Virus preparations and methods
|
|
DE602006003420D1
(de)
|
2005-04-11 |
2008-12-11 |
Crucell Holland Bv |
Virusreinigung mit ultrafiltration
|
|
DE102005047301B4
(de)
|
2005-09-30 |
2009-04-16 |
Sartorius Stedim Biotech Gmbh |
Verfahren zum Nachweis der Virenabreicherung für die Validierung von Filtern und Filtrationsprozessen
|
|
WO2007059473A2
(en)
|
2005-11-12 |
2007-05-24 |
Introgen Therapeutics, Inc. |
Methods for the production and purification of adenoviral vectors
|
|
US7754421B2
(en)
|
2005-11-18 |
2010-07-13 |
National Research Council Of Canada |
Detection of intact recombinant viruses
|
|
KR101157176B1
(ko)
|
2005-12-20 |
2012-06-20 |
삼성전자주식회사 |
세포 또는 바이러스의 농축 또는 정제용 미세유동장치 및방법
|
|
EP2018421B1
(en)
*
|
2006-04-28 |
2012-12-19 |
The Trustees of the University of Pennsylvania |
Scalable production method for aav
|
|
US7851196B2
(en)
|
2006-05-01 |
2010-12-14 |
The Regents Of The University Of California |
Methods for purifying adeno-associated virus particles
|
|
CN101516395B
(zh)
*
|
2006-09-01 |
2014-03-26 |
伯哈拉特生物技术国际有限公司 |
抗屈曲病毒感染的疫苗
|
|
JP2010512748A
(ja)
|
2006-12-15 |
2010-04-30 |
シェーリング−プラウ・リミテッド |
インフルエンザウイルスを培養物中で複製するための方法
|
|
WO2008109721A1
(en)
*
|
2007-03-06 |
2008-09-12 |
Introgen Therapeutics, Inc. |
Chromatographic methods for assessing adenovirus purity
|
|
KR20170001720A
(ko)
*
|
2007-03-14 |
2017-01-04 |
다케다 백신즈 인코포레이티드 |
바이러스 유사 입자 정제
|
|
EP2134757A2
(en)
|
2007-03-27 |
2009-12-23 |
University of Maryland, College Park |
Imprinted polymeric materials for binding various targets such as viruses
|
|
EP2155864B1
(en)
|
2007-05-04 |
2013-07-17 |
Baxter International Inc. |
Formulation of sugar solutions for continuous ultracentrifugation for virus purification
|
|
JP2011511640A
(ja)
*
|
2008-02-12 |
2011-04-14 |
サノフィ パストゥール リミテッド |
ポックス・ウイルスの精製方法
|
|
BR112012026095A2
(pt)
|
2010-04-14 |
2015-09-15 |
Emd Millipore Corp |
métodos de produção de estoques de vírus de alta pureza e altos títulos e métodos de uso dos mesmos.
|
|
US9651469B1
(en)
*
|
2016-01-27 |
2017-05-16 |
General Electric Company |
Electrostatic particle sensor
|